Cargando…

HIF2α‐induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC), the most common malignant subtype of renal cell carcinoma, is characterized by the accumulation of lipid droplets in the cytoplasm. RNASET2 is a protein coding gene with a low expression level in ovarian cancers, but it is overexpressed in poorly differentiat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quan, Yanmei, Dai, Jun, Zhou, Sian, Zhao, Lingyi, Jin, Lixing, Long, Yijing, Liu, Siwei, Hu, Yanqin, Liu, Yue, Zhao, Juping, Ding, Zhide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068329/ https://www.ncbi.nlm.nih.gov/pubmed/36728187 http://dx.doi.org/10.1002/2211-5463.13570

Ejemplares similares

Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma
por: Liu, Yifu, et al.
Publicado: (2023)

Chromosome 6 encoded RNaseT2 protein is a cell growth regulator
por: Liu, Jinglan, et al.
Publicado: (2010)

FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer
por: Ji, Mei, et al.
Publicado: (2021)

Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
por: Dufies, Maeva, et al.
Publicado: (2021)

Mammalian mitochondrial RNAs are degraded in the mitochondrial intermembrane space by RNASET2
por: Liu, Peipei, et al.
Publicado: (2017)

Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells
por: Acquati, Francesco, et al.
Publicado: (2011)

Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase
por: Lualdi, Marta, et al.
Publicado: (2015)

The failure of microglia to digest developmental apoptotic cells contributes to the pathology of RNASET2‐deficient leukoencephalopathy
por: Hamilton, Noémie, et al.
Publicado: (2020)

Regulation of mitochondrion-associated cytosolic ribosomes by mammalian mitochondrial ribonuclease T2 (RNASET2)
por: Huang, Jinliang, et al.
Publicado: (2018)

FLCN Regulates HIF2α Nuclear Import and Proliferation of Clear Cell Renal Cell Carcinoma
por: Zhao, Xuyang, et al.
Publicado: (2020)

E2F3 upregulation promotes tumor malignancy through the transcriptional activation of HIF-2α in clear cell renal cell carcinoma
por: Gao, Yu, et al.
Publicado: (2016)

A Cell-Autonomous Oncosuppressive Role of Human RNASET2 Affecting ECM-Mediated Oncogenic Signaling
por: Roggiani, Francesca, et al.
Publicado: (2019)

Human recombinant RNASET2: A potential anti-cancer drug
por: Roiz, Levava, et al.
Publicado: (2016)

RNaseT2 knockout rats exhibit hippocampal neuropathology and deficits in memory
por: Sinkevicius, Kerstin W., et al.
Publicado: (2018)

VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression
por: Ji, Jing, et al.
Publicado: (2023)

Molecular characterization and immune modulation properties of Clonorchis sinensis-derived RNASET2
por: Xu, Yanquan, et al.
Publicado: (2013)

Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
por: Acquati, Francesco, et al.
Publicado: (2019)

Expression, Location, Clinical Implication, and Bioinformatics Analysis of RNASET2 in Gastric Adenocarcinoma
por: Zeng, Zhi, et al.
Publicado: (2020)

Diagnostic and therapeutic potential of RNASET2 in Crohn’s disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretion
por: Biener-Ramanujan, Eva, et al.
Publicado: (2022)

HTLV-1 Tax directly modulates expression of the CDK6 and RNASET2 genes
por: Polakowski, Nicholas, et al.
Publicado: (2011)

3D Reconstruction of HvRNASET2 Molecule to Understand Its Antibacterial Role
por: Baranzini, Nicolò, et al.
Publicado: (2020)

Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy
por: Kettwig, Matthias, et al.
Publicado: (2021)

Hypoxia Enhances the Expression of RNASET2 in Human Monocyte-Derived Dendritic Cells: Role of PI3K/AKT Pathway
por: Monaci, Sara, et al.
Publicado: (2021)

ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma
por: Green, Yangsook Song, et al.
Publicado: (2022)

Stress-induced RNASET2 overexpression mediates melanocyte apoptosis via the TRAF2 pathway in vitro
por: Wang, Q, et al.
Publicado: (2014)

Effects of HIF-1α and HIF2α on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts
por: Biswas, Swethajit, et al.
Publicado: (2010)

Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer
por: Szendrői, Attila, et al.
Publicado: (2016)

HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
por: Hoefflin, Rouven, et al.
Publicado: (2020)

OGT/HIF-2α axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis
por: Yang, Zhou, et al.
Publicado: (2023)

Targeting HIF2α Translation with Tempol in VHL-Deficient Clear Cell Renal Cell Carcinoma
por: Sourbier, Carole, et al.
Publicado: (2012)

Long non-coding RNA LINC01234 regulates proliferation, migration and invasion via HIF-2α pathways in clear cell renal cell carcinoma cells
por: Yang, Feilong, et al.
Publicado: (2020)

ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma
por: Wang, Haofei, et al.
Publicado: (2017)

Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α
por: Fan, Yang, et al.
Publicado: (2016)

Human RNASET2 derivatives as potential anti-angiogenic agents: actin binding sequence identification and characterization
por: Nesiel-Nuttman, Liron, et al.
Publicado: (2014)

Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent
por: Nesiel-Nuttman, Liron, et al.
Publicado: (2014)

Zebrafish disease model of human RNASET2-deficient cystic leukoencephalopathy displays abnormalities in early microglia
por: Weber, Thomas, et al.
Publicado: (2020)

Antimicrobial Role of RNASET2 Protein During Innate Immune Response in the Medicinal Leech Hirudo verbana
por: Baranzini, Nicolò, et al.
Publicado: (2020)

HvRNASET2 Regulate Connective Tissue and Collagen I Remodeling During Wound Healing Process
por: Baranzini, Nicolò, et al.
Publicado: (2021)

Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma
por: Wang, Song, et al.
Publicado: (2021)

RNASET2 tag SNP but not CCR6 polymorphisms is associated with autoimmune thyroid diseases in the Chinese Han population
por: Chen, Xiao-jun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r66olshcfhvaar2l2rf7dt37ga